The global anti suicidal drugs market is anticipated to grow at a considerable CAGR of 4.1% during the forecast period (2022-2028). The global anti suicidal drugs market is growing due to the high prevalence of depression that leads to suicide attempts and the introduction of several novel drugs. As per the information provided by World Health Organization in 2021, depression is a common illness across the globe and an estimated 3.8% of the population affected, including 5.0% among adults and 5.7% among adults older than 60 years. All the major players in the anti suicidal drugs market are involved in strategic alliances such as acquisitions, partnerships, collaborations, and launching of new drugs and vaccines to provide advanced treatment for anti-suicidal treatment globally.
To Request a Sample of our Report on Anti Suicidal Drugs Market: https://www.omrglobal.com/request-sample/anti-suicidal-drugs-market
For instance, in May 2019, Allergan and Gedeon Richter Plc., had set forth that the US FDA had approved a supplemental new drug application (sNDA) for VRAYLAR (cariprazine) for expanded use to treat depressive episodes associated with bipolar I disorder (bipolar depression) in adults. Further, in March 2019, US FDA approved a Johnson & Johnson Services, Inc., nasal spray antidepressant for people resistant to other treatment and drugs. The drug esketamine nasal spray works within an hour to provide effective outcome.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
Segment Covered-
- By Drug type
- By Distribution channel
Regions Covered-
- North America
- Europe
- Asia-Pacific
Rest of the World
Competitive Landscape – Allergan, AstraZeneca, Eli Lilly and Co., GlaxoSmithKline, Pfizer Inc., and many more.
(Get 15% Discount on Buying this Report)
A full Report of Anti Suicidal Drugs Market is Available @ https://www.omrglobal.com/industry-reports/anti-suicidal-drugs-market
Global Anti Suicidal Drugs Market Report Segment
By Drug Type
- Anti-Depressant & Anti-Anxiety Drug
- NMDA Receptor Antagonist
- Antibiotic Analog
- Anti-Psychotic Drug
- Others
By Distribution Channel
- Online
- Offline
Global Anti Suicidal Drugs Market Report Segment by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Company Profiles
- Allergan Inc.
- AstraZeneca
- Eli Lilly and Co.
- Pfizer Inc.
- H. LUNDBECK A/S
- Johnson & Johnson Services, Inc.
- Merck & Co., Inc.
- NRx Pharmaceuticals, Inc.
- VistaGen Therapeutics
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
